Liver Cirrhosis Completed Phase 1 / 2 Trials for Octreotide (DB00104)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01188733Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With CirrhosisPrevention